The Trader Harbor
  • Business
  • Politics
  • World News
  • Stocks
  • Business
  • Politics
  • World News
  • Stocks

The Trader Harbor

Politics

Dr Oz to face Senate grilling on Capitol Hill in bid to run Centers for Medicare and Medicaid

by admin March 14, 2025
March 14, 2025
Dr Oz to face Senate grilling on Capitol Hill in bid to run Centers for Medicare and Medicaid

Dr. Mehmet Oz, President Donald Trump’s pick to lead the Centers for Medicare and Medicaid, will face questions in front of the Senate Committee on Finance Friday morning. 

Following the hearing, the committee will schedule a vote to send Oz’s nomination to the full Senate, where approval is likely, considering the Republican majority.

If confirmed, Oz would be in charge of nearly $1.5 trillion in federal healthcare spending. Medicare, a federal healthcare program for seniors aged 65 and up, currently provides coverage for about 65 million Americans, according to the Center for Medicare Advocacy. Medicaid, which assists people with low incomes, covers roughly 72 million Americans, according to Medicaid.gov.

A former heart surgeon who saw his fame rise through his appearances on daytime TV and 13 seasons of ‘The Dr Oz Show,’ Oz later transitioned into politics, launching an unsuccessful bid for Pennsylvania’s open Senate seat in 2022. He ultimately lost to John Fetterman, then the state’s lieutenant governor. Oz graduated from Harvard and received medical and business degrees from the University of Pennsylvania. 

Oz is expected to be grilled by Democrats during the hearing over his financial ties to a myriad of healthcare-related companies, several of which pose potential conflicts of interest for the potential CMS director.

Oz has committed to divesting many of his financial interests that pose the most obvious risk of impropriety, such as his hundreds of thousands of dollars in stock in United Health Group, a major private health insurer. He also said that if he were confirmed, he would forfeit the nearly $25 million in stock options he obtained as an advisor to a company selling health and beauty supplements.

As the administrator of CMS, Oz would make decisions related to how the government covers procedures, hospital stays and medication within the federal healthcare programs, as well as the reimbursement rates at which healthcare providers get paid for their services. 

On Thursday, Trump’s pick to lead the NIH and FDA, Dr. Jay Bhattacharya and Dr. Marty Makary, respectively, were approved in committee and will now face impending votes by the full Senate.

This post appeared first on FOX NEWS

0
FacebookTwitterGoogle +Pinterest
previous post
Clinton-era law ‘weaponized’ by Biden against pro-lifers must go, Pence group urges House GOP
next post
Federal safety rule on baby cushions goes too far, contradicts Trump agenda, legal group claims

Related Posts

Netanyahu’s meeting at White House moved amid Biden’s...

July 23, 2024

Israel stares down ‘ring of fire’ as Iran...

August 6, 2024

Huckabee demands Israel ‘aggressively investigate’ murder of Palestinian-American...

July 16, 2025

Trump stands by RFK Jr. after heated Senate...

September 5, 2025

Medical groups urge Kennedy, FDA to reexamine broad...

July 8, 2025

Pro-Ukraine Republican agrees with Trump on ‘CRAZY’ Putin,...

May 27, 2025

These 9 celebrities stand with Trump in the...

October 31, 2024

American Bar Association blasts Bondi’s decision to block...

June 12, 2025

Fetterman calls for bombing Iranian nuclear facilities: ‘Waste...

April 25, 2025

Inside how podcasters moved the voting needle with...

November 29, 2024

    Stay updated with the latest news, exclusive offers, and special promotions. Sign up now and be the first to know! As a member, you'll receive curated content, insider tips, and invitations to exclusive events. Don't miss out on being part of something special.


    By opting in you agree to receive emails from us and our affiliates. Your information is secure and your privacy is protected.

    Latest

    • Ben & Jerry’s co-founder resigns, claiming parent company Unilever ‘silenced’ its campaigning

      October 10, 2025
    • The Real Drivers of This Market: AI, Semis & Robotics

      October 10, 2025
    • S&P 500 Breaking Out Again: What This Means for Your Portfolio

      October 10, 2025
    • Could Trump win the Nobel Peace Prize after Israel-Hamas deal?

      October 10, 2025
    • RFK Jr shocked over pregnant moms protesting Trump with Tylenol: ‘Pathological’

      October 10, 2025
    • Top insurance CEO in the hot seat after scathing ad campaign exposes China ties

      October 10, 2025

    Categories

    • Business (1,416)
    • Politics (4,700)
    • Stocks (1,699)
    • Uncategorized (45)
    • World News (1,409)
    • About us
    • Contact us
    • Privacy Policy
    • Terms & Conditions

    Disclaimer: TheTraderHarbor, its managers, its employees, and assigns (collectively “The Company”) do not make any guarantee or warranty about what is advertised above. Information provided by this website is for research purposes only and should not be considered as personalized financial advice. The Company is not affiliated with, nor does it receive compensation from, any specific security. The Company is not registered or licensed by any governing body in any jurisdiction to give investing advice or provide investment recommendation. Any investments recommended here should be taken into consideration only after consulting with your investment advisor and after reviewing the prospectus or financial statements of the company.

    Copyright © 2025 thetraderharbor.com | All Rights Reserved